2/13/2022Innovent's Setback Warns Peers Prioritizing Pricing Not Good Tactic in...

2/11/2022EdiGene and Neukio Enter Collaboration to Develop Next-Generation Immu...

2/11/2022AKSO and Huadong Medicine Enter Strategic Collaboration to Develop/Com...

2/11/2022NMPA Issues the List of Reference Formulations for GQCE Studies (51st ...

2/11/2022Drug R&D and Product Registration News Digest February 2022 (1)

2/10/2022AstraZeneca Reports Q4 and FY 2021 Performance, China Revenue Surging ...

2/10/2022CDE Issues the Q&As on Issues Related to Pharmaceutical Research and E...

2/10/2022GSK Won Chinese Approval of Benlysta (belimumab) for Adult Patients wi...

2/10/2022U.S. FDA Panel Recommends Additional Trial for Lilly/Innovent Lung Ca...

2/10/2022China Is the Focus of AZ's Earnings Call for Q4 and FY 2021, BMI Fraud...

2/10/2022CDE issues the Technical Guidelines for Clinical Pharmacology Study of...

2/10/2022Why the FDA Is Making a Test Case of a Cancer Drug from China

2/10/2022China Encourages Real-world Data, Cell and Gene Therapy in Shenzhen (P...

2/9/2022CDE Solicits Comments on the Draft Guidelines for Acceptance and Evalu...

2/9/2022Lepu Biopharma Announces Proposed Public Listing in Hong Kong

2/9/2022GSK Reports Q4 and FY2021 Performance with China Related Mentions

2/9/2022Zerun Bio and Walvax to Get Additional CEPI Funding for Vaccine to Pro...

2/8/2022USPTO Webinar: Biopharma Patents in China: Litigation, Licensing, and ...

2/8/2022Sanofi Reports Slowing Chinese Growth in Q4/2021

2/8/2022MSD's China Sales Skyrocketed Driven by Strong HPV Vaccine Growth

2/8/2022Novartis China Witness 10% Innovative Medicine Sales Growth in 2021 De...

2/8/2022EdiGene and Arbor Biotechnologies Announce Worldwide Non-exclusive Lic...

2/8/2022FDA Changes Tune On China-Developed Drugs as Lilly and Innovent Draws ...

2/8/2022'I Have A Right to Change My Mind': A Top FDA Regulator Is Unapologeti...

2/7/2022Why Chinese Drugmakers Fail to Reach for the STAR (PharmaDJ)

2/7/2022FDA Says It Had No Input as Companies Developed Checkpoint Inhibitors ...

2/7/2022Mybio Publishes the 2021 China Pharma BD Transactions Report

2/7/2022Aurealis and Xbiome Entered a License Deal for AUP-16 Cell/Gene The...

2/7/2022U.S. Adds Wuxi Biologics to 'Unverified List'

2/7/2022MIIT: China to Beef Up Anti-monopoly Efforts in Pharma Industry

Page:165/789 Total number of articles:23668: [First][<<] [163] [164] [165] [166] [167] [>>] [End]